These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 37639822)

  • 1. Lead generation from N-[benzyl(4-phenylbutyl)carbamoyl]amino acid as a novel LPA
    Kobayashi Y; Uneuchi F; Naruse T; Matsuda D; Okumura-Kitajima L; Kajiyama H; Wada R; Yonemoto Y; Nakano K; Toki H; Kamigaso S; Yamagishi J; Tokura S; Kakinuma H; Kuroda S
    Eur J Med Chem; 2023 Nov; 260():115749. PubMed ID: 37639822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: from dermal fibroblasts of patients with scleroderma to tight skin 1 mouse.
    Ledein L; Léger B; Dees C; Beyer C; Distler A; Vettori S; Boukaiba R; Bidouard JP; Schaefer M; Pernerstorfer J; Ruetten H; Jagerschmidt A; Janiak P; Distler JHW; Distler O; Illiano S
    Br J Pharmacol; 2020 Sep; 177(18):4296-4309. PubMed ID: 32627178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin.
    Ohashi T; Yamamoto T
    Exp Dermatol; 2015 Sep; 24(9):698-702. PubMed ID: 25959255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of fibroblast-like synoviocytes derived from rheumatoid arthritis via lysophosphatidic acid-lysophosphatidic acid receptor 1 cascade.
    Miyabe Y; Miyabe C; Iwai Y; Yokoyama W; Sekine C; Sugimoto K; Harigai M; Miyasaka M; Miyasaka N; Nanki T
    Arthritis Res Ther; 2014 Oct; 16(5):461. PubMed ID: 25273676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic acid accelerates lung fibrosis by inducing differentiation of mesenchymal stem cells into myofibroblasts.
    Tang N; Zhao Y; Feng R; Liu Y; Wang S; Wei W; Ding Q; An MS; Wen J; Li L
    J Cell Mol Med; 2014 Jan; 18(1):156-69. PubMed ID: 24251962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidic acid signaling through its receptor initiates profibrotic epithelial cell fibroblast communication mediated by epithelial cell derived connective tissue growth factor.
    Sakai N; Chun J; Duffield JS; Lagares D; Wada T; Luster AD; Tager AM
    Kidney Int; 2017 Mar; 91(3):628-641. PubMed ID: 27927603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrogation of lysophosphatidic acid receptor 1 ameliorates murine vasculitis.
    Miyabe C; Miyabe Y; Nagai J; Miura NN; Ohno N; Chun J; Tsuboi R; Ueda H; Miyasaka M; Miyasaka N; Nanki T
    Arthritis Res Ther; 2019 Aug; 21(1):191. PubMed ID: 31429784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation.
    Sakai N; Chun J; Duffield JS; Wada T; Luster AD; Tager AM
    FASEB J; 2013 May; 27(5):1830-46. PubMed ID: 23322166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifibrogenic effects of C-C chemokine receptor type 2 antagonist in a bleomycin-induced scleroderma model.
    Ishikawa M; Yamamoto T
    Exp Dermatol; 2021 Jan; 30(1):179-184. PubMed ID: 32096250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of highly selective and orally active lysophosphatidic acid receptor-1 antagonists with potent activity on human lung fibroblasts.
    Qian Y; Hamilton M; Sidduri A; Gabriel S; Ren Y; Peng R; Kondru R; Narayanan A; Truitt T; Hamid R; Chen Y; Zhang L; Fretland AJ; Sanchez RA; Chang KC; Lucas M; Schoenfeld RC; Laine D; Fuentes ME; Stevenson CS; Budd DC
    J Med Chem; 2012 Sep; 55(17):7920-39. PubMed ID: 22894757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidic acid receptor 1 antagonist ki16425 blunts abdominal and systemic inflammation in a mouse model of peritoneal sepsis.
    Zhao J; Wei J; Weathington N; Jacko AM; Huang H; Tsung A; Zhao Y
    Transl Res; 2015 Jul; 166(1):80-8. PubMed ID: 25701366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma.
    Castelino FV; Seiders J; Bain G; Brooks SF; King CD; Swaney JS; Lorrain DS; Chun J; Luster AD; Tager AM
    Arthritis Rheum; 2011 May; 63(5):1405-15. PubMed ID: 21305523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic acid and its receptor LPA
    Srikanth M; Chew WS; Hind T; Lim SM; Hay NWJ; Lee JHM; Rivera R; Chun J; Ong WY; Herr DR
    Eur J Pharmacol; 2018 Dec; 841():49-56. PubMed ID: 30321532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A blocking peptide stabilizes lysophosphatidic acid receptor 1 and promotes lysophosphatidic acid-induced cellular responses.
    Taleb SJ; Wei J; Mialki RK; Dong S; Li Y; Zhao J; Zhao Y
    J Cell Biochem; 2021 Aug; 122(8):827-834. PubMed ID: 33847006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SKL-2841, a dual antagonist of MCP-1 and MIP-1 beta, prevents bleomycin-induced skin sclerosis in mice.
    Kimura M; Kawahito Y; Hamaguchi M; Nakamura T; Okamoto M; Matsumoto Y; Endo H; Yamamoto A; Ishino H; Wada M; Omoto A; Tsubouchi Y; Kohno M; Yoshikawa T
    Biomed Pharmacother; 2007 May; 61(4):222-8. PubMed ID: 17147981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LPA1 receptor activation promotes renal interstitial fibrosis.
    Pradère JP; Klein J; Grès S; Guigné C; Neau E; Valet P; Calise D; Chun J; Bascands JL; Saulnier-Blache JS; Schanstra JP
    J Am Soc Nephrol; 2007 Dec; 18(12):3110-8. PubMed ID: 18003779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.
    Castelino FV; Bain G; Pace VA; Black KE; George L; Probst CK; Goulet L; Lafyatis R; Tager AM
    Arthritis Rheumatol; 2016 Dec; 68(12):2964-2974. PubMed ID: 27390295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid receptor
    Hoshino Y; Okuno T; Saigusa D; Kano K; Yamamoto S; Shindou H; Aoki J; Uchida K; Yokomizo T; Ito N
    FASEB J; 2022 Apr; 36(4):e22236. PubMed ID: 35218596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain.
    González de San Román E; Manuel I; Giralt MT; Chun J; Estivill-Torrús G; Rodríguez de Fonseca F; Santín LJ; Ferrer I; Rodríguez-Puertas R
    J Neurochem; 2015 Aug; 134(3):471-85. PubMed ID: 25857358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celastrol is a novel selective agonist of cannabinoid receptor 2 with anti-inflammatory and anti-fibrotic activity in a mouse model of systemic sclerosis.
    Jiang X; Chen S; Zhang Q; Yi C; He J; Ye X; Liu M; Lu W
    Phytomedicine; 2020 Feb; 67():153160. PubMed ID: 31901889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.